CRISPR-Cas13 in malaria parasite: Diagnosis and prospective gene function identification
E Quansah, Y Chen, S Yang, J Wang, D Sun… - Frontiers in …, 2023 - frontiersin.org
Malaria caused by Plasmodium is still a serious public health problem. Genomic editing is
essential to understand parasite biology, elucidate mechanical pathways, uncover gene …
essential to understand parasite biology, elucidate mechanical pathways, uncover gene …
CRISPR/Cas9 and genetic screens in malaria parasites: small genomes, big impact
T Ishizaki, S Hernandez, MS Paoletta… - Biochemical Society …, 2022 - portlandpress.com
The∼ 30 Mb genomes of the Plasmodium parasites that cause malaria each encode∼
5000 genes, but the functions of the majority remain unknown. This is due to a paucity of …
5000 genes, but the functions of the majority remain unknown. This is due to a paucity of …
[HTML][HTML] CRISPR/Cas advancements for genome editing, diagnosis, therapeutics, and vaccine development for Plasmodium parasites, and genetic engineering of …
Malaria as vector-borne disease remains important health concern with over 200 million
cases globally. Novel antimalarial medicines and more effective vaccines must be …
cases globally. Novel antimalarial medicines and more effective vaccines must be …
Genome-wide functional screening of drug-resistance genes in Plasmodium falciparum
S Iwanaga, R Kubota, T Nishi… - Nature …, 2022 - nature.com
The global spread of drug resistance is a major obstacle to the treatment of Plasmodium
falciparum malaria. The identification of drug-resistance genes is an essential step toward …
falciparum malaria. The identification of drug-resistance genes is an essential step toward …
Paving the way: contributions of big data to apicomplexan and kinetoplastid research
In the age of big data an important question is how to ensure we make the most out of the
resources we generate. In this review, we discuss the major methods used in Apicomplexan …
resources we generate. In this review, we discuss the major methods used in Apicomplexan …
Evaluation of the Effect of Gene Duplication by Genome Editing on Drug Resistance in Plasmodium falciparum
R Kubota, T Ishino, S Iwanaga… - Frontiers in Cellular and …, 2022 - frontiersin.org
The emergence and spread of drug-resistant Plasmodium falciparum have compromised
antimalarial efficacy and threatened the global malaria elimination campaign using …
antimalarial efficacy and threatened the global malaria elimination campaign using …
[HTML][HTML] Designing hybrid CRISPR-Cas12 and LAMP detection systems for treatment-resistant Plasmodium falciparum with in silico method
Genes associated with drug resistance of first line drugs for Plasmodium falciparum have
been identified and characterized of which three genes most commonly associated with …
been identified and characterized of which three genes most commonly associated with …
[PDF][PDF] Revolutionizing Malaria Research: CRISPR unveils New Frontiers
M Moumaris - J Biotechnology and Bioprocessing, 2023 - academia.edu
The CRISPR mechanism, discovered in bacteria and archaea, operates as an adaptative
immune system at the genetic level. By using repetitive sequences, spacers derived from …
immune system at the genetic level. By using repetitive sequences, spacers derived from …
RIFINs displayed on malaria-infected erythrocytes bind both KIR2DL1 and KIR2DS1
A Sakoguchi, SG Chamberlain, AM Mørch, TE Harrison… - bioRxiv, 2024 - biorxiv.org
To discriminate between our own cells and foreign cells such as a pathogen, natural killer
cells are armed with inhibitory and activating immune receptors. In some cases, such as the …
cells are armed with inhibitory and activating immune receptors. In some cases, such as the …
A scalable CRISPR-Cas9 gene editing system facilitates CRISPR screens in the malaria parasite Plasmodium berghei
Many Plasmodium genes remain uncharacterised due to low genetic tractability. Previous
large scale knockout screens have only been able to target about half of the genome in the …
large scale knockout screens have only been able to target about half of the genome in the …